Solventum Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Solventum Corp.
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
/ 
Frequently asked questions
To buy Solventum Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Solventum Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Solventum Corp. is SOLV:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Solventum Corp. has its primary listing on New York Stock Exchange. You can trade Solventum Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Solventum Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Solventum Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Solventum Corp..